Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001080709-21-000031
Filing Date
2021-08-05
Accepted
2021-08-05 16:56:50
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arna-20210630.htm   iXBRL 10-Q 1331003
2 EX-10.2 arna-20210630xex102.htm EX-10.2 213078
3 EX-10.9 arna-20210630xex109.htm EX-10.9 9891
4 EX-31.1 arna-20210630xex311.htm EX-31.1 9356
5 EX-31.2 arna-20210630xex312.htm EX-31.2 8037
6 EX-32.1 arna-20210630xex321.htm EX-32.1 6113
  Complete submission text file 0001080709-21-000031.txt   5502762

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20210630.xsd EX-101.SCH 28140
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arna-20210630_cal.xml EX-101.CAL 44934
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arna-20210630_def.xml EX-101.DEF 131873
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20210630_lab.xml EX-101.LAB 425594
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20210630_pre.xml EX-101.PRE 273473
12 EXTRACTED XBRL INSTANCE DOCUMENT arna-20210630_htm.xml XML 867166
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

EIN.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 211149204
SIC: 2834 Pharmaceutical Preparations